Annual Retained Earnings
-$148.07 M
-$40.00 M-37.01%
31 December 2023
Summary:
LAVA Therapeutics NV annual retained earnings is currently -$148.07 million, with the most recent change of -$40.00 million (-37.01%) on 31 December 2023. During the last 3 years, it has fallen by -$114.68 million (-343.50%). LVTX annual retained earnings is now -980.47% below its all-time high of -$13.70 million, reached on 31 December 2019.LVTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$168.93 M
-$12.21 M-7.79%
30 September 2024
Summary:
LAVA Therapeutics NV quarterly retained earnings is currently -$168.93 million, with the most recent change of -$12.21 million (-7.79%) on 30 September 2024. Over the past year, it has dropped by -$27.02 million (-19.04%). LVTX quarterly retained earnings is now -405.99% below its all-time high of -$33.39 million, reached on 31 December 2020.LVTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LVTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.0% | -19.0% |
| 3 y3 years | -343.5% | -145.9% |
| 5 y5 years | - | - |
LVTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -343.5% | at low | -145.9% | at low |
| 5 y | 5 years | -980.5% | at low | -406.0% | at low |
| alltime | all time | -980.5% | at low | -406.0% | at low |
LAVA Therapeutics NV Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$168.93 M(+7.8%) |
| June 2024 | - | -$156.72 M(+5.6%) |
| Mar 2024 | - | -$148.48 M(+0.3%) |
| Dec 2023 | -$148.07 M(+37.0%) | -$148.07 M(+4.3%) |
| Sept 2023 | - | -$141.91 M(+5.3%) |
| June 2023 | - | -$134.71 M(+10.4%) |
| Mar 2023 | - | -$122.01 M(+12.9%) |
| Dec 2022 | -$108.07 M | -$108.07 M(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$93.46 M(-1.1%) |
| June 2022 | - | -$94.46 M(+5.8%) |
| Mar 2022 | - | -$89.29 M(+17.2%) |
| Dec 2021 | -$76.16 M(+128.1%) | -$76.16 M(+10.9%) |
| Sept 2021 | - | -$68.70 M(+11.5%) |
| June 2021 | - | -$61.60 M(+14.3%) |
| Mar 2021 | - | -$53.90 M(+61.5%) |
| Dec 2020 | -$33.39 M(+143.6%) | -$33.39 M |
| Dec 2019 | -$13.70 M | - |
FAQ
- What is LAVA Therapeutics NV annual retained earnings?
- What is the all time high annual retained earnings for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual retained earnings year-on-year change?
- What is LAVA Therapeutics NV quarterly retained earnings?
- What is the all time high quarterly retained earnings for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly retained earnings year-on-year change?
What is LAVA Therapeutics NV annual retained earnings?
The current annual retained earnings of LVTX is -$148.07 M
What is the all time high annual retained earnings for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual retained earnings is -$13.70 M
What is LAVA Therapeutics NV annual retained earnings year-on-year change?
Over the past year, LVTX annual retained earnings has changed by -$40.00 M (-37.01%)
What is LAVA Therapeutics NV quarterly retained earnings?
The current quarterly retained earnings of LVTX is -$168.93 M
What is the all time high quarterly retained earnings for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly retained earnings is -$33.39 M
What is LAVA Therapeutics NV quarterly retained earnings year-on-year change?
Over the past year, LVTX quarterly retained earnings has changed by -$27.02 M (-19.04%)